Khalil Sheibani

4.5k total citations
82 papers, 3.4k citations indexed

About

Khalil Sheibani is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Khalil Sheibani has authored 82 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pathology and Forensic Medicine, 27 papers in Oncology and 25 papers in Immunology. Recurrent topics in Khalil Sheibani's work include Lymphoma Diagnosis and Treatment (44 papers), Chronic Lymphocytic Leukemia Research (24 papers) and Viral-associated cancers and disorders (13 papers). Khalil Sheibani is often cited by papers focused on Lymphoma Diagnosis and Treatment (44 papers), Chronic Lymphocytic Leukemia Research (24 papers) and Viral-associated cancers and disorders (13 papers). Khalil Sheibani collaborates with scholars based in United States, Taiwan and Germany. Khalil Sheibani's co-authors include Henry Rappaport, Jerome S. Burke, Carl D. Winberg, Hector Battifora, Jonathan Ben‐Ezra, Raymond R. Tubbs, Robert Stroup, Sung Sik Shin, Lawrence M. Weiss and Douglas W. Blayney and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Khalil Sheibani

82 papers receiving 3.2k citations

Peers

Countries citing papers authored by Khalil Sheibani

Since Specialization

Citations

This map shows the geographic impact of Khalil Sheibani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalil Sheibani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalil Sheibani more than expected).

Fields of papers citing papers by Khalil Sheibani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalil Sheibani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalil Sheibani. The network helps show where Khalil Sheibani may publish in the future.

Co-authorship network of co-authors of Khalil Sheibani

This figure shows the co-authorship network connecting the top 25 collaborators of Khalil Sheibani. A scholar is included among the top collaborators of Khalil Sheibani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalil Sheibani. Khalil Sheibani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mutually exclusive driver mutations identifies 2 separate primaries in a collision tumor initially interpreted as a solitary lung adenocarcinoma with tumor heterogeneity 2024 ·Respiratory Medicine Case Reports ·(unknown), Khalil Sheibani, Mohammad A. Vasef	1
2	Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma). 1999 ·PubMed ·Bharat N. Nathwani, (unknown), (unknown), A. M. Levine, Khalil Sheibani	36
3	Antigenic phenotypes of hairy cell leukemia and monocytoid B-cell lymphoma: An immunohistochemical evaluation of 66 cases 1992 ·Human Pathology ·Robert Stroup, Khalil Sheibani	24
4	A Novel Biotinylated Probe Specific for Hyaluronate 1992 ·The American Journal of Surgical Pathology ·Norio Azumi, Charles B. Underhill, Elliott Kagan, Khalil Sheibani	25
5	Monocytoid B-cell lymphoma in patients with Sjögren's syndrome: A clinicopathologic study of 13 patients 1991 ·Human Pathology ·Sung Sik Shin, Khalil Sheibani, Andrew J. Fishleder, Jonathan Ben‐Ezra, (unknown), Chae H. Koo, Jerome S. Burke, Raymond Tubbs, Henry Rappaport	61
6	Malignant histiocytosis X. A distinct clinicopathologic entity 1991 ·Cancer ·Jonathan Ben‐Ezra, (unknown), Norio Azumi, Georges Delsol, Robert Stroup, Khalil Sheibani, Henry Rappaport	55
7	Ber-EP4 Antibody as a Discriminant in the Differential Diagnosis of Malignant Mesothelioma Versus Adenocarcinoma 1991 ·The American Journal of Surgical Pathology ·Khalil Sheibani, Sung Sik Shin, (unknown), Lawrence M. Weiss	117
8	Genotype and phenotype: A practical approach to the immunogenetic analysis of lymphoproliferative disorders 1990 ·Human Pathology ·Anna M. Wu, Carl D. Winberg, Khalil Sheibani, Anne Colombero, R. Bruce Wallace, Henry Rappaport	5
9	Additional Evidence That “Plasmacytoid T-Cell Lymphoma” Associated with Chronic Myeloproliferative Disorders Is of Macrophage/Monocyte Origin 1990 ·American Journal of Clinical Pathology ·Chae H. Koo, David Y. Mason, (unknown), Jonathan Ben‐Ezra, Khalil Sheibani, Henry Rappaport	25
10	Tumor DNA Content in Resectable, Primary Colorectal Carcinoma 1989 ·Annals of Surgery ·William A. Kokal, (unknown), Khalil Sheibani, (unknown), Elliot Prager, (unknown), Jose J. Terz	73
11	Relationship between eosinophil density and T-cell activation markers in lymph nodes of patients with Hodgkin's disease 1989 ·Human Pathology ·Jonathan Ben‐Ezra, Khalil Sheibani, William G. Swartz, Robert Stroup, S. Thomas Traweek, (unknown), Henry Rappaport	9
12	Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the head and neck region 1988 ·The American Journal of Surgery ·William A. Kokal, (unknown), Khalil Sheibani, (unknown), J. David Beatty, Daniel U. Riihimaki, Lawrence D. Wagman, Jose J. Terz	82
13	Monocytoid b-cell lymphoma clinicopathologic study of 21 cases of a unique type of low-grade lymphoma 1988 ·Cancer ·Khalil Sheibani, Jerome S. Burke, William G. Swartz, Auayporn Nademanee, Carl D. Winberg	111
14	Signet-Ring Cell Melanoma 1988 ·The American Journal of Surgical Pathology ·Khalil Sheibani, Hector Battifora	88
15	Variability in interpretation of immunohistologic findings in lymphoproliferative disorders by hematopathologists. A comprehensive statistical analysis of interobserver performance 1988 ·Cancer ·Khalil Sheibani, Bharat N. Nathwani, William G. Swartz, Jonathan Ben‐Ezra, (unknown), Jerome S. Burke, John L. Kennedy, Chae H. Koo, Carl D. Winberg	15
16	T-cell-rich lymphoproliferative disorders morphologic and immunologic differential diagnoses 1988 ·Cancer ·Carl D. Winberg, Khalil Sheibani, Jerome S. Burke, Anna M. Wu, Henry Rappaport	25
17	Antigenic phenotype of Langerhans cell histiocytosis: An immunohistochemical study demonstrating the value of LN-2, LN-3, and Vimentin 1988 ·Human Pathology ·Norio Azumi, Khalil Sheibani, William G. Swartz, Robert Stroup, Henry Rappaport	25
18	Distinction between Undifferentiated (Small Noncleaved) and Lymphoblastic Lymphoma 1987 ·The American Journal of Surgical Pathology ·(unknown), Khalil Sheibani, Hector Battifora, Carl D. Winberg, Henry Rappaport	9
19	Leu-Ml Antigen in Human Neoplasms 1986 ·The American Journal of Surgical Pathology ·Khalil Sheibani, Hector Battifora, (unknown), Henry Rappaport	133
20	Antikeratin antibodies in tumor diagnosis. Distinction between seminoma and embryonal carcinoma 1984 ·Cancer ·Hector Battifora, Khalil Sheibani, Raymond R. Tubbs, (unknown), Tung‐Tien Sun	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact